Medical Cannabis in USA – Find Out More!
After California legalized marijuana for medical purposes in 1996, medical cannabis has seen a significant rise in the state and public support and has become a growing industry. Fast forward to the current year, medical cannabis is now available for use in 33 states and is used to treat many symptoms and illnesses. Before you go buy medical marijuana seeds USA, here are some sets of information that might benefit you.
Facts about Medicinal Cannabis in the United States of America
- The marijuana industry is worth more than the Gross Domestic Product of 9 US States.
The legal cannabis sector has an economic impact between $20 to 23 billion in 2017. It is forecasted to reach as high as $77 billion in 2022. These numbers are actually comparable to the GDP of West Virginia and Idaho, in accordance with the Bureau of Economic Analysis. The numbers are worth more than the GDP of nine states like Delaware, North Dakota, South Dakota, and Alaska.
- The cannabis industry has employed five times as many Americans as coal.
Reports by a cannabis market research and data analysis firm have estimated that the industry has provided jobs for at least 250,000 people. Those are jobs that are directly involved with handling cannabis plants. If you consider one of America’s staple blue collar industries, coal mining, they have employed 52,300 people in 2018. Cannabis significantly produced more jobs. Another report has stated that by 2022, the industry can grow into a 330,000 job industry, which will beat the 268,000 worker count of steel and iron mills.
- The median salary of medical cannabis workers is actually higher than the US average.
In 2018, records show that the marijuana industry salary median was valued at $58,511. On the other hand, the median salary for US workers as a whole was $52,863, as provided by Glassdoor data. The difference is actually very significant at 10.7%.
- Early Medical Cannabis Use in America
As traced in history, cannabis entered the United States Pharmacopeia in 1850, as a treatment for diseases like alcoholism, tetanus, rabies, neuralgia, cholera, dysentery, anthrax, leprosy, tonsillitis, gout, leprosy, incontinence, uterine bleeding, and excessive menstrual bleeding. Medical cannabis than was actually available in pharmacies and grocery stores during the latter half of the 19th century. The prices were relative to other drugs and do not require doctor’s prescriptions. Early medical marijuana was commonly available in tinctures from the earlier manufacturers.
- Main Cannabinoid Drugs
Currently, there are four cannabinoid drugs that can be prescribed in the United States: Marinol, Syndros, Cesamet, and Epidiolex. For non-prescription use, CBD that is taken from hemp is legal federally, but legality is varied depending on the state.
- Dronabinol – This is THC that is synthetically manufactured. It has been approved by the FDA in pill form as Marinol, and an oral solution as Syndros.
- Marinol – Marinol is a gelatin shell encapsulation of a sesame oil suspension of dronabinol. It was FDA-approved in 1985 and was used mainly for the treatment of nausea and vomiting associated with chemotherapy, and additionally in 1992 as a stimulant of appetite of weight loss as a result of HIV/AIDS. In terms of classification, it is a Schedule III, as of the latest update. The drug was developed by Unimed Pharmaceuticals, although the initial research was managed by the government budget. Unimed is now known as Solvay Pharmaceuticals.
- Syndros – The liquid formulation of Dronabinol is approved for chemotherapy-induced nausea and vomiting, including AIDS-related weight loss. The FDA approval was released in July 2016 and was classified as Schedule II in March 2017. Syndors is manufactured by the company Insys Therapeutics, which has given a massive contribution to the defeat of cannabis legalization in Arizona, in attempts to protect their market share for the newly developed drug. Syndros has been made available for prescription in July 2017.
- Nabilone – Nabilone is a synthetic cannabinoid which has proven their therapeutic use as an analgesic and antiemetic. It is similar to THC, which is the primary compound naturally occurring in Cannabis.
- Cesamet – In 1985, Cesamet received FDA approval for treatment of chemotherapy-induced nausea and vomiting. It was initially manufactured by Eli Lilly until discontinuation in 1989. Then, the rights to produce were sold to Valeant Pharmaceuticals in 2004. FDA has approved sales resumption in 2006.
- Cannabidiol – commonly known as CBD, it is one of the 113 cannabinoids in cannabis plants and accounts for up to 40 percent of the extract. This phytocannabinoid was discovered in 1940. It is non-psychoactive and has been approved by the FDA as the drug Epidiolex.
- Epidiolex – This is the liquid oral formulation of CBD that was approved for the treatment of Lennox-Gastaut Syndrome, childhood-onset epilepsy, and Dravet Syndrome, a type of epilepsy with seizures that are often triggered by hot temperatures. FDA approval was finalized in June 2018, and assigned as a Schedule V by September 2018. Epidiolex is manufactured by Greenwich Biosciences, a subsidiary of GW Pharmaceuticals. It became available for prescription on November 2018.
- Non-prescription Use – In addition to the treatment of seizures, CBD is commonly used by some patients under the belief that they have many other health benefits. These claims are still under intense studies and experiments.
- Other Things to Know about Cannabinoids
Cannabinoids are chemical compounds that are basically what makes cannabis beneficial to people. People usually only know about THC. Also known as delta-9-tetrahydrocannabinol, THC has the psychoactive effect smokers yearn for. The amount of THC present per plant depends on the strains, but there are non-psychoactive cannabinoids with many benefits.
- Cannabidiol – CBD relieves convulsions, anxiety, nausea, and inflammations. It has similar characteristics with THC.
- Cannabinol – CBN is slightly psychoactive and has benefits of decreasing intraocular pressure and seizure occurrence.
- Cannabichromene – CBC stimulates the analgesic effects or pain relief and has sedative-like calming effects.
- Cannabigerol – CBG has tranquilizing properties and antimicrobial assets, as well as lowers intraocular pressure.
- Tetrahydrocannabivarin – THCV is showing promise for type 2 diabetes and related metabolic disorders.
There’s still a long way to go for medical cannabis, but technology and research are trying to cope up in a faster way. Because of continuous studies and curious minds, the future of cannabis is looking brighter as days pass. You can start to buy medical marijuana seeds, USA, to try them for yourself, or if you want you can also consult a specialist for more advice.